Tenaya Therapeutics, Inc. (TNYA)
0.6901
-0.01
(-0.73%)
USD |
NASDAQ |
Aug 28, 16:00
0.6903
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Cash from Operations (Quarterly) : -3.552M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.552M |
| March 31, 2026 | -19.23M |
| December 31, 2025 | -13.94M |
| September 30, 2025 | -15.60M |
| June 30, 2025 | -15.61M |
| March 31, 2025 | -23.11M |
| December 31, 2024 | -18.39M |
| September 30, 2024 | -19.84M |
| June 30, 2024 | -23.62M |
| March 31, 2024 | -28.66M |
| December 31, 2023 | -21.92M |
| September 30, 2023 | -23.64M |
| June 30, 2023 | -26.22M |
| Date | Value |
|---|---|
| March 31, 2023 | -30.29M |
| December 31, 2022 | -22.68M |
| September 30, 2022 | -27.56M |
| June 30, 2022 | -25.43M |
| March 31, 2022 | -28.76M |
| December 31, 2021 | -16.35M |
| September 30, 2021 | -16.66M |
| June 30, 2021 | -12.02M |
| March 31, 2021 | -15.79M |
| December 31, 2020 | -10.40M |
| September 30, 2020 | -9.534M |
| June 30, 2020 | -7.274M |
| March 31, 2020 | -8.238M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -83.11M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.28M |
| Sarepta Therapeutics, Inc. | 197.07M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.159M |
| Cash from Financing (Quarterly) | 0.909M |
| Free Cash Flow | -52.59M |
| Free Cash Flow Per Share (Quarterly) | -0.0171 |
| Free Cash Flow to Equity (Quarterly) | 2.457M |
| Free Cash Flow to Firm (Quarterly) | -3.711M |
| Free Cash Flow Yield | -39.44% |